Revised Stage Group Definitions:
Stage IIB: Previously defined as T3N0M0, this stage has been reclassified to T1-T2N1M0. This change reflects a more accurate representation of prognosis where tumor size and nodal status are considered more comprehensively.
Stage IIIA: Updated from T1-T2N1M0 to T3N0-N1M0, adjusting the classification to better correlate with survival outcomes.
Stage IIIC: Modified from T3-T4N1M0 to T4N1M0, narrowing the criteria to ensure that the classification more closely aligns with the prognosis observed in patient populations.
Elimination of Stage 0: Stage 0, which represented in situ disease or high-grade squamous intraepithelial lesions (HSIL) and was not an invasive malignancy, has been removed. This adjustment prevents the over-treatment of pre-malignant conditions and aligns treatment protocols more closely with clinical significance.
Swasth Parivar — a letter to your family, every fortnight
Dr Harsh Shah writes on recovery after surgery, which symptoms need a scan, and the questions patients actually ask in OPD. No advertising.
Your number is used for this letter and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.